Standout Papers
Citation Impact
Citing Papers
Global phosphorylation analysis of β-arrestin–mediated signaling downstream of a seven transmembrane receptor (7TMR)
2010 StandoutNobel
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
2005 StandoutNobel
Mechanisms of Thrombus Formation
2008 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Dynamic personalities of proteins
2007 StandoutNature
Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs)
2012
High Affinity Ca2+-binding Site in the Serine Protease Domain of Human Factor VIIa and Its Role in Tissue Factor Binding and Development of Catalytic Activity
1995
Endocytosis without clathrin coats
2001
Contribution of platelets to tumour metastasis
2011 Standout
Human Fibrinogen
1988
β-Arrestin-dependent Regulation of the Cofilin Pathway Downstream of Protease-activated Receptor-2
2007
Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction
1995
Management of Sepsis
2006
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Development and Disease in Proteinase-Deficient Mice
1998
The molecular basis of blood coagulation
1988 Standout
MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
1998 Standout
Regulated portals of entry into the cell
2003 StandoutNature
Angiogenesis in cancer and other diseases
2000 StandoutNature
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
1997 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Thrombin signalling and protease-activated receptors
2000 StandoutNature
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2
2004 StandoutNobel
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway
1998 StandoutNobel
The microenvironment of the tumour–host interface
2001 StandoutNature
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
2016
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Endocrine Regulation of Energy Metabolism by the Skeleton
2007 Standout
Emerging Biological Principles of Metastasis
2017 Standout
A Multigene Family Encoding a Diverse Array of Putative Pheromone Receptors in Mammals
1997 StandoutNobel
Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice
2004
Survey of the year 2003 commercial optical biosensor literature
2004
The gut microbiota — masters of host development and physiology
2013 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Disseminated Intravascular Coagulation
1999 Standout
Kinetics of inhibition of tissue‐type and urokinase‐type plasminogen activator by plasminogen‐activator inhibitor type 1 and type 2
1988
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Perspectives on Oxygen Sensing
1999 StandoutNobel
Survey of the year 2005 commercial optical biosensor literature
2006
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
2013 Standout
Biochemical and biological aspects of the plasminogen activation system
1990
The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins
1993
Tissue factor and PAR signaling in tumor progression
2007
Molecular cloning and expression of human hepatocyte growth factor
1989 StandoutNature
Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism
1991 StandoutNobel
The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis
2007
Activation of human blood coagulation factor XI independent of factor XII.
1991
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
1989
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
1990
Serpin Structure, Mechanism, and Function
2002 Standout
Protease-Activated Receptor (PAR) 2, but not PAR1, Signaling Promotes the Development of Mammary Adenocarcinoma in Polyoma Middle T Mice
2008
Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism
1998
Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice
2012
Regulation of cellular energy metabolism
1982
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
2009 StandoutNobel
Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
1990
Surface receptors for urokinase plasminogen activator
1988
Fast Time Scale Dynamics of Protein Backbones: NMR Relaxation Methods, Applications, and Functional Consequences
2006
Functions of Ceramide in Coordinating Cellular Responses to Stress
1996 StandoutScience
The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.
1990
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Liver Regeneration
1997 StandoutScience
Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
1994 StandoutNobel
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Better reception for urokinase
1990 Nature
Two-Photon Absorbing Nanocrystal Sensors for Ratiometric Detection of Oxygen
2009 StandoutNobel
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
1989
Trinitrobenzoylated poly(d-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator
1986
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
2000
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
Rates of various reactions catalyzed by ATP synthase as related to the mechanism of ATP synthesis.
1991 StandoutNobel
Large Enhancement of Functional Activity of Active Site-Inhibited Factor VIIa Due to Protein Dimerization: Insights into Mechanism of Assembly/Disassembly from Tissue Factor
2005
cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family.
1989 StandoutNobel
The Use of Soluble Fibrin in Evaluating the Acute and Chronic Hypercoagulable State
1999
An optical method for measurement of dioxygen concentration based upon quenching of phosphorescence.
1987
Transduction of Receptor Signals by ß-Arrestins
2005 StandoutScienceNobel
Works of Lars C. Petersen being referenced
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
2009
Regulation of chemotaxis by the cytoplasmic domain of tissue factor
2004
Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human–murine species compatibility study
2004
Inhibition of coagulation factors by recombinant barley serpin BSZx
1996
Factor VIIa-induced p44/42 Mitogen-activated Protein Kinase Activation Requires the Proteolytic Activity of Factor VIIa and Is Independent of the Tissue Factor Cytoplasmic Domain
1999
Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII - tissue factor interaction
1993
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling
2012 Nature
Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416
1990
Autoactivation of human recombinant coagulation factor VII
1989
Involvement of the hydrophobic stack residues 39–44 of factor VIIa in tissue factor interactions
1994
Inhibitory Properties of Separate Recombinant Kunitz‐Type‐Protease‐Inhibitor Domains from Tissue‐Factor‐Pathway Inhibitor
1996
Signal Transduction via the Mitogen-activated Protein Kinase Pathway Induced by Binding of Coagulation Factor VIIa to Tissue Factor
1998
Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles
2011
Blockade of Tissue Factor
2003
Tissue factor-factor VIIa–specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration
2004
Inhibitory Properties of a Novel Human Kunitz-Type Protease Inhibitor Homologous to Tissue Factor Pathway Inhibitor
1996
Solution Structure and Backbone Dynamics of the Human α3-Chain Type VI Collagen C-Terminal Kunitz Domain,
1997
Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development
2010
Diversity in catalytic properties of single chain and two chain tissue-type plasminogen activator
1991
Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-d -lysine on plasminogen activation
1985
One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity.
1988
Tissue factor–mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor
2001
Antiapoptotic effect of coagulation factor VIIa
2003
A Sensitive Solid-Phase Immunosorbent Assay for Tissue-Type Plasminogen Activator Activity in Plasma Using Trinitrobenzoylated Poly-D-Lysine as a Stimulator for Plasminogen Activation
1987
Fibrin Affinity and Clearance of t-PA Deletion and Substitution Analogues
1990
The effect of energization on the apparent Michaelis–Menten constant for oxyge in nmitochondrial respiration
1974
Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator
1986
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
Plasmin Induces Cyr61 Gene Expression in Fibroblasts Via Protease-Activated Receptor-1 and p44/42 Mitogen-Activated Protein Kinase–Dependent Signaling Pathway
2002